Sign in

Trial result ·

Symptoms and treatment response to florensocatib and inhaled tobramycin in bronchiectasis: Post hoc analysis of two randomized trials.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study took a fresh look at data from earlier trials. The trials were SAVE-BE, with 224 people, and TORNASOL, with 357 people. All people in them had bronchiectasis. In each trial, people were put into groups by chance. SAVE-BE tested a drug called florensocatib against a dummy drug. TORNASOL tested tobramycin, an antibiotic that people breathe in. The team asked if symptom levels at the start changed the results.

What they found

In SAVE-BE, florensocatib cut the rate of flare-ups compared with the dummy drug. The relative risk was 0.47. It was 0.53 in people with more symptoms. It was 0.40 in people with fewer symptoms. But florensocatib did not clearly ease symptoms. In TORNASOL, tobramycin led to real gains on a symptom score. In people with many symptoms, the gain passed an 8-point mark that matters. It also eased bronchitis-type symptoms. The gains were larger in people who had more symptoms at the start.

What it means for patients

The authors say symptom levels at the start may help sort people. Symptom levels might point to different responses to anti-inflammatory drugs versus antibiotics. The authors say this supports its potential as a simple, practical sorting tool. Such a tool might help guide care for each person.

Why it is not certain yet

The authors say these findings only raise ideas to test further. The questions were asked after the trials, not planned at the start. Checks like this can find links by chance. The drugs were tested in separate trials, not against each other. New trials would be needed to confirm the idea.

Source

Symptoms and treatment response to florensocatib and inhaled tobramycin in bronchiectasis: Post hoc analysis of two randomized trials.

PubMed · PMID 42594878

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Bronchiectasis publications